Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership
Learn More
close
Fred Hutch - Cures Start Here®
Research
Pioneering Scientific Research
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Log In to Your Fundraiser
Attend an Event
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Fearless Science Needs Us
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Submit
Donate
Now
Submit
Research
Pioneering Scientific Research
Research Areas
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Fundraise for Fred Hutch
Log In to Your Fundraiser
Attend an Event
Support Our Science
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Fearless Science Needs Us
Other Ways to Give
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Donate Now
Business Development News
Business Development
Search and Filter
Apply
Clear all
Results per Page:
20
5
10
20
50
100
Investment in business development pays dividends for research, patients
Fred Hutch tech transfer specialists help scientists navigate path to bringing innovations to patients
Hutch News - September 02, 2021
Tags
business development
business development and strategy
Matthias Stephan
Brian Till
Raphael Gottardo
Clinical Research
CAR t-cell
immunotherapy
targeted t cell immunotherapy
adoptive t cell therapy
nanoparticle
Translational Data Science IRC
data science
Share
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
News Releases - March 02, 2021
Tags
COVID-19
COVID-19 Prevention Network
COVID-19 Clinical Research Center
COVID positive participants
COVID-19 CRC
COVID-19 Timeline
COVID Research Center
Weintraub Graduate Student Award
Stanley R Riddell
hematopoietic transplant
immunotherapy
IIRC
non-hodgkin lymphoma
David G Maloney
Damian Green
human molecular genetics
business development and strategy
Hans-Peter Kiem
cell and gene therapy
gene editing
Clinical Research
biostatistics
Peter Gilbert
Holly Janes
Jim Kublin
Lawrence Corey
CoVPN
HVTN
Public Health Sciences
public health
Vaccine Development
viral infection
WHI
womens health initiative
clinical trials
Laura Matrajt
Share
Hutch research helps launch new genomic medicine company
Ensoma receives $70 million in financing to develop genome modification technologies via a single injection
Hutch News - February 11, 2021
Tags
human molecular genetics
business development and strategy
Hans-Peter Kiem
Kiem Lab
hematopoietic stem cell
hematopoietic stem cell transplant
cell and gene therapy
gene editing
Clinical Research
Share
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Hutch News - February 05, 2021
Tags
hematopoietic transplantation
immunotherapy
Stanley R Riddell
Geoffrey Hill
David G Maloney
Damian Green
Bezos Family Immunotherapy Clinic
IIRC
CAR t-cell
Juno Therapeutics
u.s. food and drug administration
non-hodgkin lymphoma
Markers of B-Cell Stimulation as Potential Predictors of Non-Hodgkin Lymphoma
Share
Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel
The newly-approved CAR T-cell therapy was developed in part by Fred Hutch physician-scientists
News Releases - February 05, 2021
Tags
David G Maloney
Clinical Research
CAR t-cell
business development
business development and strategy
Share
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
News Releases - February 04, 2021
Tags
Public Health Sciences
Jihong Bai
Lawrence Corey
business development
cancer treatment
epigenetics
pathogen-associated malignancies
cellular therapy
Jesse Bloom
cancer prevention
philanthropy
Good News
Vaccine and Infectious Disease
hematology
microbial epigenetics
commercialization
Susan Bullman
Taran Gujral
hematopoietic stem cell transplant
COVID-19
VIDD
Heather Greenlee
Human Biology
graft versus host disease
HIV-AIDS
lung disease
Gary Lyman
Tumor specific translational research
Basic Sciences
Colorectal Cancer
Steven Pergam
artificial intelligence
Laura Matrajt
Share
New awards to spur innovation, commercialization in life sciences research
Funding from Washington Research Foundation continues longstanding collaboration with Fred Hutch
Hutch News - February 01, 2021
Tags
business development
philanthropy
Taran Gujral
Human Biology
Tumor specific translational research
lung disease
artificial intelligence
commercialization
Good News
Share
How Fred Hutch is using science to get back to doing science
Physical distancing, masks, testing and lots of research drive 'back-to-campus' strategy
Hutch News - May 19, 2020
Tags
COVID-19
Steven Pergam
Nicole Robinson
Julie McElrath
Trevor Bedford
McElrath Lab
Vaccine and Infectious Disease
coronavirus
Seattle Cancer Care Alliance
Share
Inside scorpion venom: A future Rx for arthritis?
Tiny scorpion-derived proteins deliver arthritis drugs to joints in rat study
Hutch News - March 04, 2020
Tags
Jim Olson
Clinical Research
Rheumatoid Arthritis
protein engineering
Project Violet
optides
tumor paint
Blaze Biosciences
Share
Fred Hutch research a GeekWire Award finalist for Health Innovation of the Year
Other finalists include Fred Hutch spinoffs Adaptive Biotechnologies and Blaze Bioscience
Hutch News - February 19, 2020
Tags
Matthias Stephan
Clinical Research
CAR t-cell
bioengineering
immunology
Good News
Adaptive Biotechnologies
Blaze Biosciences
Transplant and Immunotherapy
Stephan Lab
Ovarian Cancer
Share
High-altitude altruism: Seeking cures at 17,600 feet
Fred Hutch scientist, senior leader will hike the Himalayas to raise money for cancer research
Hutch News - February 14, 2020
Tags
Jennifer Adair
Adair Lab
Nicole Robinson
Climb to Fight Cancer
mountain climbing
Share
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Hutch News - September 26, 2019
Tags
Multiple Myeloma
Transplant and Immunotherapy
Damian Green
Stanley R Riddell
chimeric antigen receptor
genetically engineered t cells
Juno Therapeutics
clinical trials
Clinical Research
american society of hematology
scientific conferences
ASH
ASH 2019
Share
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Hutch News - August 02, 2019
Tags
Public Health Sciences
Clinical Research
Vaccine and Infectious Disease
Human Biology
Cyrus Ghajar
Slobodan Beronja
Geoff Hill Lab
Andrew McGuire
Sujatha Srinivasan
David Fredricks
Chapuis Lab
Anton Sholukh
Lucas Sullivan
business development and strategy
Roland K Strong
metastatic breast cancer
Ovarian Cancer
cytomegalovirus
bone marrow transplantation
epstein-barr virus
bacterial vaginosis
myeloproliferative disorders
TCR
Acute Lymphoblastic Leukemia
Good News
commercialization
Share
Fred Hutch adds senior leaders from Celgene and Amazon to board of trustees
Dr. Corsee Sanders and Sean Boyle add science, technology, finance and innovation expertise to cancer research center’s board
News Releases - July 09, 2019
Tags
board of trustees
D. Gary Gilliland
Juno Therapeutics
matt mcilwain
Share
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Hutch News - November 16, 2018
Tags
Colleen Delaney
Nohla Therapeutics
cord blood transplant
Filippo Milano
HIV Cure
HIV AIDS
Leukemia
Cord Blood Program
Timothy Ray Brown
Good News
Clinical Research
Share
Seattle Times' Pacific NW Magazine profiles Fred Hutch
Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible
Hutch News - May 17, 2018
Tags
Pacific NW Magazine
Fred Hutch
closing in on a cure
D. Gary Gilliland
Cures2025
curative therapies
next generation immunotherapies
immunotherapy
bone marrow transplantation
blood cancer
Leukemia
Lymphoma
business development
business development and strategy
partnerships
Share
A focus on partnerships at Hutch/Merck summit
Research on the immune system aims to stop infectious diseases and cancer
Hutch News - May 11, 2018
Tags
infection-related cancers
D. Gary Gilliland
Nicole Robinson
business development and strategy
Business Development
Denise Galloway
Human Biology
Julie McElrath
Vaccine and Infectious Disease Division (VIDD)
Vaccine development - Viral cancers
Share
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
Hutch News - March 30, 2018
Tags
big data
D. Gary Gilliland
Matthew Trunnell
Denise Galloway
Leland Hartwell
Christine Gregoire
Cancers
biotech
Adaptive Biotechnologies
Nohla Therapeutics
life sciences discovery fund
immune system
immunotherapy
Immunology
cancer research
malaria
Director's Office
Cancer etiology - prevention - outcomes
Human Biology
Christopher J Kemp
Vijayakrishna Gadi
Eddie Mendez
Clinical Research
Colleen Delaney
Translational Data Science Integrated Research Center
hutch data commonwealth
Share
Scientists-turned-entrepreneurs share lessons learned launching startups
From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found
Hutch News - March 26, 2018
Tags
Basic Sciences
Clinical Research
Vaccine and Infectious Disease
Public Health Sciences
Business Development
business development and strategy
Mark B Roth
Colleen Delaney
Raphael Gottardo
startups
licensing technology
cord blood transplant
cord blood
suspended animation
computational biology
Nohla Therapeutics
Share
Seattle mayor eager to realize the future of health care right here
Jenny Durkan addresses local life sciences representatives at Hutch roundtable
Hutch News - March 05, 2018
Tags
Bruce E Clurman
Director's Office
Nicole Robinson
Business Development
Good News
Share
Fred Hutchinson Cancer Research Center
Investors & Industry
Business Development
News
Last Modified, April 12, 2021